UNRESECTABLE ENDOMETRIAL CARCINOMA
Clinical trials for UNRESECTABLE ENDOMETRIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE ENDOMETRIAL CARCINOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE ENDOMETRIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Custom-Made cancer vaccine shows promise in advanced tumors
Disease control Recruiting nowThis study tests a personalized vaccine made from a patient's own tumor proteins, given alone or with the immunotherapy drug pembrolizumab. The goal is to see if the combination is safe and helps the immune system attack advanced solid tumors. About 132 people with various advanc…
Matched conditions: UNRESECTABLE ENDOMETRIAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New drug combo plus radiation targets tough uterine cancer
Disease control Recruiting nowThis early-stage trial is testing whether combining two cancer drugs (lenvatinib and pembrolizumab) with a shorter course of pelvic radiation is safe for people with recurrent or unresectable endometrial cancer. The study aims to find the best dose of lenvatinib when used in this…
Matched conditions: UNRESECTABLE ENDOMETRIAL CARCINOMA
Phase: PHASE1 • Sponsor: Aaron Wolfson • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC